CNA Staff, Dec 10, 2025 / 18:30 pm

Pro-life advocates are calling for action as top health officials deny reports that they are delaying a promised safety review of the abortion pill.

The Food and Drug Administration (FDA), an agency of the U.S. Department of Health and Human Services, “has delayed a promised review of safety data” until after midterm elections at Commissioner Marty Makary’s request, a Tuesday report by Bloomberg Law claimed, citing unnamed sources.

The U.S. Department of Health and Human Services (HHS) has denied the claim, saying it is “baseless.”

“Assertions that the FDA is slow walking this review for political purposes are baseless,” an HHS spokesperson told CNA.

“FDA takes the time necessary to conduct comprehensive scientific reviews, and that is what Dr. Mak

See Full Page